References

Arsenical-based cancer drugs

10.1016/j.ctrv.2007.05.001 · 2007 · External reference

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

10.1056/nejm199811053391901 · 1998 · External reference

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

10.1200/jco.2001.19.18.3852 · 2001 · External reference

Arsenic trioxide—an old drug rediscovered

10.1016/j.blre.2010.04.001 · 2010 · External reference

Mechanisms of action of arsenic trioxide

2002 · External reference

Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown

1999 · External reference

Tumor cells resistant to a microtubuledepolymerizing hemiasterlin analogue, HTI-286, have mutations in α- or β-tubulin and increased microtubule stability

10.1021/bi049300+ · 2004 · External reference

Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors

10.1038/sj.neo.7900123 · 2000 · External reference

Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis

10.1182/blood.v96.4.1525 · 2000 · External reference

Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor

2002 · External reference

Arsenic trioxide enhances radiation response of 9L glioma in the rat brain

10.1667/rr3069 · 2003 · External reference

Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy

10.1016/j.ijrobp.2004.12.058 · 2005 · External reference

Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells

1999 · External reference

Disrupting tumour blood vessels

10.1038/nrc1628 · 2005 · External reference

Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancer

10.1002/cncr.24975 · 2010 · External reference

Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors

10.1016/j.ijrobp.2008.07.043 · 2008 · External reference

DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents

10.1038/sj.bjc.6603515 · 2007 · External reference

Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools?

10.1007/s00259-010-1451-z · 2010 · External reference